Harbour Investments’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
PBA
OAG
DM
DTC
SI
Harbour Investments's GMAB Position: Q2 2026 in Review
Harbour Investments reduced its Genmab (GMAB) stake by 5.3% in Q2 2026, selling an estimated $319 and leaving 213 shares worth $5.85K. The position accounts for ﹤0.01% of the portfolio, ranked #3622.
Harbour Investments first reported a position in GMAB in Q1 2021 and has held it in 21 quarters since. The position peaked at $6.36K in Q4 2022. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.
- Harbour Investments held 213 shares of Genmab worth $5.85K as of Q2 2026.
- Harbour Investments sold 12 Genmab shares in Q2 2026, an estimated $319.
- Genmab made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3622 holding.
- Harbour Investments first reported a position in Genmab in Q1 2021 and has held it in 21 quarters since.
- Harbour Investments's Genmab position peaked at $6.36K in Q4 2022.
- 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.
Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.